Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XENT
2901
PUT
DELISTED
Intersect ENT, Inc
XENT
| $2.14M | ﹤0.01% |
85,900
-67,400
| -44% | -$1.37M |
|
2902
Chewy
CHWY
$9.63B
| $2.14M | ﹤0.01% |
73,631
+62,493
| +561% | +$1.6M |
|
2903
CALL
Cboe Global Markets
CBOE
$29.9B
| $2.14M | ﹤0.01% |
17,800
-2,000
| -10% | -$235K |
|
2904
Enerpac Tool Group
EPAC
$1.93B
| $2.13M | ﹤0.01% |
81,946
+27,747
| +51% | +$677K |
|
2905
CALL
KB Home
KBH
$3.59B
| $2.13M | ﹤0.01% |
62,200
-17,600
| -22% | -$608K |
|
2906
PUT
Textron
TXT
$15.4B
| $2.13M | ﹤0.01% |
47,800
-1,500
| -3% | -$69.5K |
|
2907
CALL
Huntsman Corp
HUN
$1.77B
| $2.12M | ﹤0.01% |
87,900
+22,200
| +34% | +$514K |
|
|
PGNX
2908
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $2.12M | ﹤0.01% |
417,414
+220,865
| +112% | +$1.17M |
|
2909
National Grid
NGG
$81.3B
| $2.12M | ﹤0.01% |
38,247
+11,279
| +42% | +$580K |
|
2910
Helix Energy Solutions
HLX
$1.41B
| $2.12M | ﹤0.01% |
220,224
+79,256
| +56% | +$686K |
|
2911
AptarGroup
ATR
$8.61B
| $2.12M | ﹤0.01% |
18,329
-11,538
| -39% | -$1.31M |
|
2912
Glaukos
GKOS
$10.6B
| $2.12M | ﹤0.01% |
38,896
+19,966
| +105% | +$1.21M |
|
2913
Laureate Education
LAUR
$5.28B
| $2.12M | ﹤0.01% |
120,313
+1,200
| +1% | +$19.8K |
|
2914
Credit Acceptance
CACC
$6.08B
| $2.12M | ﹤0.01% |
4,784
-7,465
| -61% | -$3.29M |
|
2915
Aurinia Pharmaceuticals
AUPH
$2.04B
| $2.12M | ﹤0.01% |
104,375
+34,115
| +49% | +$314K |
|
|
GES
2916
PUT
DELISTED
Guess Inc
GES
| $2.12M | ﹤0.01% |
94,500
+19,600
| +26% | +$365K |
|
|
AQUA
2917
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $2.12M | ﹤0.01% |
111,652
+44,711
| +67% | +$802K |
|
2918
Tennant Co
TNC
$1.26B
| $2.11M | ﹤0.01% |
27,127
+9,097
| +50% | +$678K |
|
2919
Caleres
CAL
$487M
| $2.11M | ﹤0.01% |
88,812
-16,540
| -16% | -$374K |
|
2920
Casella Waste Systems
CWST
$5.69B
| $2.11M | ﹤0.01% |
45,848
+22,750
| +98% | +$1M |
|
|
AVTA
2921
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.11M | ﹤0.01% |
80,657
+9,026
| +13% | +$202K |
|
2922
CALL
Stanley Black & Decker
SWK
$15.7B
| $2.1M | ﹤0.01% |
12,700
+4,300
| +51% | +$666K |
|
|
NAV
2923
DELISTED
Navistar International
NAV
| $2.1M | ﹤0.01% |
72,561
+14,377
| +25% | +$442K |
|
2924
AeroVironment
AVAV
$9.45B
| $2.1M | ﹤0.01% |
33,947
+9,811
| +41% | +$588K |
|
2925
Buckle
BKE
$2.37B
| $2.09M | ﹤0.01% |
77,457
+5,305
| +7% | +$126K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.